Connect with us
PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTC: MDXXF) showed investors some incoming revenue when the psychedelic drug company released its unaudited third-quarter earnings. PharmAla reported C$139,847...
Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) reported a 20.3% increase in annual revenue for its 2024 fiscal year, which ended March 31, as it...
RBC Capital Markets initiated coverage on Compass Pathways (NASDAQ: CMPS) with an “Outperform” rating on Tuesday, citing the potential for $2.3 billion in peak revenues from...
The U.S. Food and Drug Administration has intensified its warning against Diamond Shruumz-brand products as reports of severe illnesses linked to the company’s edibles continue to...
Much is still unknown about how and why psychedelics are an effective tool in treating mood disorders, but a new study revealed that the drugs work,...
As the Food and Drug Administration nears a decision on MDMA-assisted therapy for PTSD, the Multidisciplinary Association for Psychedelic Studies (MAPS) appears to be recalibrating its...
As an August deadline for the U.S. Food and Drug Administration looms regarding approval for psychedelic therapies, a coalition of well-known scientific researchers took it upon...
Clearmind said its preclinical studies demonstrated its drug’s effectiveness and was tolerable for patients. Clearmind Medicine Inc. (Nasdaq: CMND) announced that the U.S. Food and Drug...
Braxia last reported earnings in March when it told investors that its situation was dire. Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) informed investors that...
Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) reported a third-quarter loss for the period ending May 31, as it continues to restructure its operations. According to filings,...
